Literature DB >> 35507567

Acute respiratory infection rates in primary care anticipate ICU bed occupancy during COVID-19 waves.

Montserrat Guillen1, Ignasi Bardes Robles2, Ester Bordera Cabrera2, Xénia Acebes Roldán2, Catalina Bolancé1, Daniel Jorba3, David Moriña4.   

Abstract

BACKGROUND: Bed occupancy in the ICU is a major constraint to in-patient care during COVID-19 pandemic. Diagnoses of acute respiratory infection (ARI) by general practitioners have not previously been investigated as an early warning indicator of ICU occupancy.
METHODS: A population-based central health care system registry in the autonomous community of Catalonia, Spain, was used to analyze all diagnoses of ARI related to COVID-19 established by general practitioners and the number of occupied ICU beds in all hospitals from Catalonia between March 26, 2020 and January 20, 2021. The primary outcome was the cross-correlation between the series of COVID-19-related ARI cases and ICU bed occupancy taking into account the effect of bank holidays and weekends. Recalculations were later implemented until March 27, 2022.
FINDINGS: Weekly average incidence of ARI diagnoses increased from 252.7 per 100,000 in August, 2020 to 496.5 in October, 2020 (294.2 in November, 2020), while the average number of ICU beds occupied by COVID-19-infected patients rose from 1.7 per 100,000 to 3.5 in the same period (6.9 in November, 2020). The incidence of ARI detected in the primary care setting anticipated hospital occupancy of ICUs, with a maximum correlation of 17.3 days in advance (95% confidence interval 15.9 to 18.9).
INTERPRETATION: COVID-19-related ARI cases may be a novel warning sign of ICU occupancy with a delay of over two weeks, a latency window period for establishing restrictions on social contacts and mobility to mitigate the propagation of COVID-19. Monitoring ARI cases would enable immediate adoption of measures to prevent ICU saturation in future waves.

Entities:  

Mesh:

Year:  2022        PMID: 35507567      PMCID: PMC9067638          DOI: 10.1371/journal.pone.0267428

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Saturation of hospital and especially ICU beds is the reason to declare nationwide lockdowns during COVID-19 pandemic [1, 2]. Early warnings to predict hospital occupancy waves mostly rely on the number of confirmed cases, contagion rates, and adherence to self-isolation measures [3-7]. These figures, however, are affected by changes in social behavior, screening strategies, and testing methodologies that are not necessarily stable over the course of the pandemic [8, 9]. Many reports have shown that prompt interventions can prevent the surge in the number of cases [10-14], but early timing of the imposition of restrictions may have devastating economic consequences. Therefore, there is an urgent need to identify fast, consistent, and reliable indicators for anticipating the resurge [15] or decline [16] of a new wave of COVID-19. Despite huge research efforts around the world to fight against COVID-19 pandemic, the role of general practitioners has not been extensively investigated, although they are on the front line for identifying patients with COVID-19 presenting with mild symptoms. Since March 26, 2020, general practitioners from the primary health care setting in Catalonia, Spain, were enforced to report all cases of acute respiratory infections caused by COVID-19, flu, or other causes. The objective of this study was to assess whether the series of daily cases of COVID-19-related diagnoses of ARI could anticipate the behavior of the series of ICU bed occupancy, so that the former figure could be an early warning indicator of potential in-patient care saturation.

Methods

Design and setting

This was a retrospective study of data recorded prospectively in the registry of the Integrated Public Health System of Catalonia (SISCAT), which provides universal free full-health care coverage for the citizens of Catalonia. Catalonia is an autonomous community on the northeastern part of Spain (official 2020 population, 7,727,029 inhabitants) and a geographical area of 32,108 km2 about the size of Belgium. The majority of the population lives in Barcelona (the capital) and its metropolitan area and along the Mediterranean coast, while counties in the interior are much less densely populated (overall population density 241/km2). There are 434 primary health care centers in the public network, with health care provided by general practitioners who are specialists in family and community medicine, pediatricians, nurses, and social workers. These centers, also linked to the network of public county and regional hospitals, are usually closed during weekends and bank holidays, but there are emergency centers in the primary care setting providing 24/7 service. For the purpose of this registry-based study, the requirement of a written informed consent was waived. The researchers only analyzed anonymized and aggregated data. The Clinical Research Ethics Committee of Hospital Universitari de Bellvitge in L’Hospitalet de Llobregat, Barcelona (Spain) approved the study (date December 31, 2020, reference PR454/20).

Participants and definitions

All general practitioners from the primary care network were required to register cases of their patients diagnosed with ARI. ARI was defined as an infection that may interfere with normal breathing. It can affect just the upper respiratory system, or just the lower respiratory system (ICD10 codes related to SNOMED CT: influenza, adenoviral respiratory disease, viral respiratory infection, viral upper respiratory tract infection, viral lower respiratory infection, viral pleurisy, and severe acute respiratory syndrome; flu terms were excluded). The diagnosis of ARI was made clinically by the general practitioner. The infection was assumed to be related to COVID-19 only if a confirmed positive result was obtained by a real-time reverse-transcriptase-polymerase chain reaction (rRT-PCR) and/or antigen testing. General practitioners were also required to register the date when ARI was suspected and confirmed to be related to COVID-19, flu, or other causes. Once patients were reported, they were not registered again if they went to see their general practitioner for subsequent visits. The study data form recording COVID-19-related ARI cases was completed by the physicians in charge of the patients, and the data were stored in the registry system on the SISCAT database server. Consistency of data was confirmed by SISCAT.

Data collection

Data were collected between March 25, 2020 and January 20, 2021, and included aggregated total cases of COVID-19-related ARI diagnosed in the primary care setting and registered in the SISCAT database and total number of ICU beds occupied by COVID-19 patients. The number of cases and the number of beds were calculated per 100,000 residents in order to provide results comparable to other regions. To evaluate the stability of the results, data collection was extended to March 27, 2022. The total number of cases of ARI related to COVID-19 was gathered daily and the time series was updated according to SARS–CoV-2 test results. Daily series of occupied ICU beds in all Catalonian hospitals (both private and public) was also compiled for this study. At midnight, information regarding the number of beds that were occupied in each hospital was sent to the central system as well as the daily total of ICU beds, from which the time series of ICU occupancy was compiled. The series of total COVID-19 detected cases was not evaluated because the strategies and intensity of screening varied throughout the observation period. For example, patients with mild symptoms or even those that are asymptomatic (approximately one third) [17] did not always visit a general practitioner. The total number of ICU beds available in Catalonia is over 11.6 per 100,000 inhabitants (around 900). However, in Spring 2020, hospitals had to convert hospital areas into ICUs due to a dramatic increase in COVID-19-infected patients, as a result of which the total ICU occupancy related to COVID-19 reached as much as 19.7 per 100,000 inhabitants (1,528 beds) [18].

Outcome measures

The primary outcome measure was the cross-correlation between the series of COVID-19-related ARI cases and ICU bed occupancy by COVID-19-infected patients, taking into account the effect of bank holidays and weekends, expressed as the delay (in days) from the point of maximum correlation between the series of ARI cases per 100,000 inhabitants and ICU bed occupancy per 100,000 inhabitants.

Statistical analysis

The daily series of ARI rates and the daily series of ICU occupancy rates were compared visually. The series of ARI showed weekly peaks that corresponded to a high value of cases occurring on Mondays (or first day after a Monday bank holiday) and a low value corresponding to weekends and holidays. The series of ICU occupancy was smooth as it reflected the inflow of new admissions and discharges. Data from April 1, 2020, onwards were selected to eliminate the lack of complete ICU data of March 2020, and to be able to analyze up to a one month gap between ARI and ICU peaks. Firstly, the series of ARI cases was filtered to remove the effect of the first working day of the week, holidays, and weekends via a multivariate log-linear regression model with the corresponding binary variables. The lagged ARI series and the filtered series were compared with the series of ICU occupancy. The lags from 1 to up to 30 days were analyzed to compare the dynamics of ARI with those showing up later in ICU occupancy. The series of ICU occupancy rates and the series of unfiltered (and filtered) ARI rates were analyzed. The optimal lag was found by maximizing the linear cross-correlation between the ICU and the ARI series. By interpolating the results, an optimal fractional lag was obtained. Correlation was assessed with the Pearson’s correlation coefficient (r). Statistical significance was set at P < 0.05. To provide a confidence interval, a bootstrap method was used. Each replicated series of ARI and ICU was the result of a bootstrapped version of the time series using the Box-Cox and Loess-based decomposition bootstrap [19]. The analysis was repeated and the empirical 95% highest and 5% lowest maximum correlation lag values were provided as bootstrap confidence interval estimates. All statistical analyses were performed with the use of the R program, version 3.6.1. All tests were two-tailed, and the number of replicates in bootstrap confidence interval calculation was 2,000.

Results

Time series of daily indicators

During the study period, a delay appeared between ARI case waves and ICU waves (Fig 1). After the first wave, the weekly incidence of ARI cases increased from 252.7 per 100,000 in August 2020 to 496.5 in October 2020 (294.2 in November 2020), while the average number of ICU beds occupied by COVID-19 patients rose from 1.7 per 100,000 to 3.5 in the same period and jumped to 6.9 per 100,000 in November 2020 (Table 1).
Fig 1

Daily series of acute respiratory infection rates (cases per 100,000 inhabitants, solid line), filtered series (dashed line) and ICU occupancy (beds per 100,000 inhabitants, shaded) by date (mm-yyyy).

Table 1

Average weekly incidence of Acute Respiratory Infection (ARI) cases with Codid-19 diagnosed in Primary Care and Average Intensive Care Unit (ICU) Bed Occupancy of Covid-19 patients, all per 100,000 habitants by months in Catalonia, Spain.

Month (year 2020)ARI related to Covid-19 diagnosed in Primary Care per 100,000 (average weekly incidence)ICU Covid-19 beds per 100,000 (average occupancy)
April200.715.5
May69.24.2
June43.61.1
July153.70.7
August252.71.7
September333.32.0
October496.53.5
November294.26.9
December230.24.7

Outcomes

For the unfiltered series of COVID-19-related ARI rates and the series of ICU rates, the maximum cross-correlation was obtained at lag 18 (r = 0.40, P < 0.001). Interpolation indicated that the higher correlation was at 17.3 days (95% confidence interval [CI], 15.9 to 18.9). After filtering the effect of bank holidays and weekends in the ARI series, the highest lagged correlation (r = 0.52, P < 0.001) was found at 17.1 days, (95% CI, 16.7 to 17.3) which was over 2 weeks. Fig 2 shows the cross-correlation between the filtered ARI rates series and the ICU rates series. Table 2 extends the data timeframe. We present estimates of anticipation lag time in days and the corresponding CI, using a monthly timeframe rolling window until March 2022.
Fig 2

Cross-correlogram between filtered ARI rates and ICU occupancy rates (right).

The x-axis indicates the number of lags.

Table 2

Anticipation lag (in days) of Acute Respiratory Infection (ARI) cases with Codid-19 diagnosed in Primary Care (original and filtered) for Intensive Care Unit (ICU) Bed Occupancy of Covid-19 patients, in a rolling window from April 2020 to March 2022 in Catalonia, Spain (with confidence intervals, CI).

Data windowAnticipation lag of original ARI series (CI)Anticipation lag of filtered ARI series (CI)
Apr. 20 –Jan. 2117,3 (15,5;17,9)17,1 (16,5;17,7)
May 20- Feb. 2118,9 (16,9;19,1)18,8 (18,6;19,1)
Jun. 20 –Mar.2118,7 (18,5;19,1)18,8 (18,8;19,0)
Jul. 20 –Apr. 2118,7 (17,2;19,1)18,8 (18,7;19,0)
Aug. 20- May 2118,8 (16,8;19,1)19,0 (18,5;19,1)
Sep. 20 –Jun-2118,3(15,5;19,0)18,7(18,6;19,2)
Oct. 20 –Jul. 2118,7 (17,0;19,0)18,9 (18,6;19,0)
Nov 20 –Aug. 2118,7 (17,2;19,2)18,6 (18,6;19,6)
Dec. 20 –Sep. 2119,0 (17,2;19,2)18,6 (18,6;19,6)
Jan. 21- Oct. 2119,0 (17,2;19,2)18,7 (18,6;19,6)
Feb. 21 –Nov. 2118,8 (17,2;19,1)18,7 (18,6;19,0)
Mar. 21 –Dec. 21*19,0 (17,2;19,1)18,7 (18,6;19,5)
Apr. 21 –Jan. 22*18,7 (14,8;18,9)16,7 (17,1;18,9)
May 21 –Feb. 22*12,7 (11,9;12,7)12,6 (12,5;12,7)
Jun. 21 –Mar. 22*12,7 (11,6;12,7)12,7 (11,9;12,7)

*Omicron.

Cross-correlogram between filtered ARI rates and ICU occupancy rates (right).

The x-axis indicates the number of lags. *Omicron.

Discussion

According to the analysis of data from a regional population-based registry, this study found that ARI diagnoses related to COVID-19 infection made by general practitioners correlated significantly with ICU bed occupancy by COVID-19-infected patients over COVID-19 waves recorded in Catalonia in 2020. Interestingly, an increase in the number of ARI cases could anticipate an increase in ICU bed occupancy, with a delay of 17.3 days (slightly more than 2 weeks). This means to have available a consistent time gap for anticipating ICU occupancy saturation when a COVID-19 wave of cases appears to start. Therefore, there is sufficient time to impose restrictions to diminish social contacts and reduce the speed of contagion and the incidence of COVID-19-related ARI cases with subsequent decrease of COVID-19-related ICU bed occupancy. We also found that ARI series is a simple and easy early warning signal, with the advantage that ARI series are gathered directly by general practitioners and accordingly does not depend upon the number of detected cases in the general population. Total cases might be influenced by the type of testing and screening strategies implemented in the region. For example, if most new cases affect a younger segment of the population, the incidence of COVID-19-related ARI and subsequent hospitalizations may not increase as much as the incidence of COVID-19 [20]. Underreporting of cases [21] and false-negative and false-positive COVID-19 test results [22, 23] discourage the use of series of total positive cases. To our knowledge, only a few studies have assessed early signals associated with ICU requirements and some have only investigated Internet searches and social media data [24, 25]. A retrospective quantitative analysis from the Ile de France region in France (12.1 million inhabitants, population density equal 1,000/km2) from the first wave (data from February 20 to May 5, 2020) [26] portrayed a few early indicators of the number of COVID19 patients requiring ICU care during the epidemic crisis, none of them being the identification of ARI cases. The only signal that was found to flag earlier than the series of daily ARI cases was the daily number of COVID-19-related telephone calls received by the emergence medical services (EMS), showing a 23-day delay in the correlation curve. Dispatching ambulances, proportion of positive rRT-PCR tests, emergency department visits, and general practitioner visits were associated with COVID-19 ICU patients with an anticipation delay of 15, 14, 13, and 12 days, respectively. Qualitative analysis was reported to provide similar conclusions from August 1, 2020 to September 15, 2020, but no additional estimates were provided [26]. In relation to general practitioner visits, it should be noted that data corresponded to SOS médicins, that is, the number of COVID-19 diagnoses made by a private network of general practitioners who performed only emergency visits on a 24 hour and 7 day basis at home. This is a remarkably different perspective that ARI diagnoses made by general practitioners in the primary care setting of entire Catalonia. Additionally, the merits of the daily number of emergency calls received by the EMS needs to be confirmed for subsequent and/or smaller waves and its application to other countries and comparability could be challenged by the type of medical assessment provided and how the use of emergency resources is incited in different places. Moreover, EMS calls usually do not distinguish call-backs, call types such as low acuity or other than medical demands, and implementation of computerized triage [27]. EMS call services may be severely disrupted by peak number of calls and even blackouts [28], which suggests that most EMS are likely to need pandemic crisis redefinitions [27]. We performed a data analysis of the daily curves for a period longer than that reported in previous studies, in a less densely populated region and including the initial days of the third wave. It did not contain subregional or patient specific characteristics analysis. We assumed the full capacity to perform ARI diagnosis by general practitioners, the consistency of diagnostic criteria over the observation period, and the reliability of the SISCAT database. This method has been successfully implemented by the local authorities. When Primary Care diagnoses of ARI increased (or decreased), subsequent ICU occupancy increase (or decreased) followed about three weeks later. This neat indicator did not depend on recorded infection rates (which could be contingent on test availability) and was only challenged when Primary Care facilities became fully saturated during the Omicron variant wave from December 2021 to January 2022. We expect that in future outbreaks similar analyses will help anticipating ICU occupancy. With Omicron our analysis reveals a shorter anticipation lag in days, which could be explained by the fact that Primary Care facilities were overloaded at that time. We have considered the availability of outpatient treatments like Paxlovid may be game changing, but we have ruled out its effect because Paxlovid was approved by the European Medicines Agency only on January 28, 2022 and introduced in Spain very recently. The implication of the present findings is that we obtained an early warning signal of ICU bed occupancy by COVID-19 patients that could be generated in the primary care setting and introduced in digital monitoring dashboards [29, 30]. The role of general practitioners in the health care system is therefore crucial for anticipating hospital pressure and for supporting policy decisions aimed at anticipating ICU saturation. We also note that applying our approach to other health systems requires consideration of the local context, criteria for hospital and ICU admission and reporting protocols. For example, in the US, there are 30 ICU beds/100,000 approximately [31, 32], which triples the rate in the region analyzed here. In conclusion, the evolution of COVID-19-related ARI cases per 100,000 inhabitants is a simple tool for flagging up any future COVID-19 waves. Despite the complex situation and challenges posed by COVID-19 pandemic to health services, daily registry of COVID-19-related ARI diagnoses made in the primary care setting represents a novel and useful indicator of ICU bed occupancy in advance. 28 Mar 2022
PONE-D-21-02244
Acute Respiratory Infection Rates in Primary Care Anticipate ICU Bed Occupancy During COVID-19 Waves
PLOS ONE Dear Dr. Guillen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The present investigation is well designed and written. However, the main limitation is represented by the fact that data are somewha old (2020). We suggest the Authors to clearly explain why and how their findings are still clinically useful. Please submit your revised manuscript by May 12 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chiara Lazzeri Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following financial disclosure: "This study was supported by grants from the Spanish Ministry of Science and Innovation (code PID2019-105986GB-C21) (MG, CB) and Instituto de Salud Carlos III (code COV20/00115) (DM), Madrid, Spain, and Institució Catalana de Recerca i Estudis Avançats  ICREA Academia (MG), Barcelona, Spain" Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary). 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an important question but it has also been informally understood since the beginning of the pandemic that outpatient cases �  hospitalization 2 weeks later �  death 4 weeks later (roughly). That said, they provide specificity for this general concept. Also, by tying it to GP visit they establish a somewhat uniform definition of outpatient severity (i.e. asymptomatic or very mild cases wouldn’t visit GP, generally). I have some concerns about immediate relevance given that the data are in pandemic terms quite old (2020). On the other hand, the concept is an important one and I would therefore strongly support publication. Introduction A nice, concise description of what is known and the problem. Very well written. Methods Good description of patient population, appropriate to only use index visits for ARI with PCR confirmed COVID-19. Appropriate to include positive rapid antigen as specificity is high for those tests. US has 27 ICU beds/100,000, so this should be addressed in the Discussion; applying this to other health systems will require consideration of the local context. Criteria for hospital and ICU admission may also vary. And, reporting requirements vary by country. This makes sense in a proper organized national health system, but not in places like my country which lack a true health system. Unfortunately. Adjustment for holidays and weekends and day of week effects is important. Not being a biostatistician I am not able to judge whether your approach was appropriate, but it seem to be so. Results Again, very concise. Was the 17-day lag consistent throughout the study period? Also, this research was done with the ancestral variant. We are now on to omicron. Would be much more compelling if this study including much more recent data and looked at whether the lag was consistent despite changing variants and changing treatments. And, the availability of outpatient treatments like Paxlovid may be game changing. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Mark H. Ebell MD, MS [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
8 Apr 2022 See file "Response to Reviewers.pdf" Submitted filename: Response to Reviewers.pdf Click here for additional data file. 11 Apr 2022 Acute Respiratory Infection Rates in Primary Care Anticipate ICU Bed Occupancy During COVID-19 Waves PONE-D-21-02244R1 Dear Dr. Guillen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chiara Lazzeri Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 13 Apr 2022 PONE-D-21-02244R1 Acute Respiratory Infection Rates in Primary Care Anticipate ICU Bed Occupancy During COVID-19 Waves Dear Dr. Guillen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chiara Lazzeri Academic Editor PLOS ONE
  23 in total

1.  Projecting demand for critical care beds during COVID-19 outbreaks in Canada.

Authors:  Affan Shoukat; Chad R Wells; Joanne M Langley; Burton H Singer; Alison P Galvani; Seyed M Moghadas
Journal:  CMAJ       Date:  2020-04-08       Impact factor: 8.262

2.  COVID-19 in Spain: view from the eye of the storm.

Authors:  María José Sierra Moros; Susana Monge; Berta Suarez Rodríguez; Lucía García San Miguel; Fernando Simón Soria
Journal:  Lancet Public Health       Date:  2020-12-07

3.  System impacts of the COVID-19 pandemic on New York City's emergency medical services.

Authors:  David J Prezant; Elizabeth A Lancet; Rachel Zeig-Owens; Pamela H Lai; David Appel; Mayris P Webber; James Braun; Charles B Hall; Glenn Asaeda; Bradley Kaufman; Michael D Weiden
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-11-09

4.  Projecting hospital utilization during the COVID-19 outbreaks in the United States.

Authors:  Seyed M Moghadas; Affan Shoukat; Meagan C Fitzpatrick; Chad R Wells; Pratha Sah; Abhishek Pandey; Jeffrey D Sachs; Zheng Wang; Lauren A Meyers; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-03       Impact factor: 11.205

5.  Experts' request to the Spanish Government: move Spain towards complete lockdown.

Authors:  Oriol Mitjà; Àlex Arenas; Xavier Rodó; Aurelio Tobias; Joe Brew; José M Benlloch
Journal:  Lancet       Date:  2020-03-27       Impact factor: 79.321

6.  Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England.

Authors:  Simon de Lusignan; Jamie Lopez Bernal; Maria Zambon; Oluwafunmi Akinyemi; Gayatri Amirthalingam; Nick Andrews; Ray Borrow; Rachel Byford; André Charlett; Gavin Dabrera; Joanna Ellis; Alex J Elliot; Michael Feher; Filipa Ferreira; Else Krajenbrink; Jonathan Leach; Ezra Linley; Harshana Liyanage; Cecilia Okusi; Mary Ramsay; Gillian Smith; Julian Sherlock; Nicholas Thomas; Manasa Tripathy; John Williams; Gary Howsam; Mark Joy; Richard Hobbs
Journal:  JMIR Public Health Surveill       Date:  2020-04-02

7.  COVID-19 Testing: The Threat of False-Negative Results.

Authors:  Colin P West; Victor M Montori; Priya Sampathkumar
Journal:  Mayo Clin Proc       Date:  2020-04-11       Impact factor: 7.616

8.  Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.

Authors:  Lara Jehi; Xinge Ji; Alex Milinovich; Serpil Erzurum; Amy Merlino; Steve Gordon; James B Young; Michael W Kattan
Journal:  PLoS One       Date:  2020-08-11       Impact factor: 3.240

9.  False-positive COVID-19 results: hidden problems and costs.

Authors:  Elena Surkova; Vladyslav Nikolayevskyy; Francis Drobniewski
Journal:  Lancet Respir Med       Date:  2020-09-29       Impact factor: 30.700

10.  Retrospective analysis of the possibility of predicting the COVID-19 outbreak from Internet searches and social media data, China, 2020.

Authors:  Cuilian Li; Li Jia Chen; Xueyu Chen; Mingzhi Zhang; Chi Pui Pang; Haoyu Chen
Journal:  Euro Surveill       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.